130 likes | 354 Vues
Open Public Hearing. Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC]. Cardiovascular and Renal Drugs Advisory Committee June 16, 2005. Open Public Hearing. Gary A. Puckrein, Ph.D. National Minority Health Month Foundation.
E N D
Open Public Hearing • Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing • Gary A. Puckrein, Ph.D. National Minority Health Month Foundation Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing 3. B. Waine Kong, J.D., Ph.D. CEO – American Association of Black Cardiologists [ABC] Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing • Debra Lee Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing 5. Shomarka Omar Y. Keita, M.D., D.Phil. Medical Officer -Department of Human Services, District of Columbia Research Associate - Anthropology Department, Smithsonian Institution * Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing • Jonathan Kahn, J.D., Ph.D. Assistant Professor Hamline University School of Law Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing 7. Charles L. Curry, M.D., FACC, FACP President - International Society on Hypertension in Blacks Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing 8. Basil Halliday, M.Sc. President & CEO - BDH Clinical Research Services * Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing • Charles N. Rotimi, Ph.D. National Human Genome Center Howard University * Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing • Charmaine Royal, Ph.D. National Human Genome Center Howard University * Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing • Olivia Carter-Pokras, Ph.D. Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing • Lucille C. Norville Perez, MD National Health Director - National Association for the Advancement of Colored People Cardiovascular and Renal Drugs Advisory Committee June 16, 2005
Open Public Hearing 13. Dianna Wells Cardiovascular and Renal Drugs Advisory Committee June 16, 2005